Clinical Trials Medical Discoveries Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule By Helus Pharma Jul 21, 2026 Enrollment continues in EMBRACE, the second pivotal study of the Phase 3 PARADIGM Program
Clinical Trials Medical Discoveries Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule By Helus Pharma Jul 21, 2026 Enrollment continues in EMBRACE, the second pivotal study of the Phase 3 PARADIGM Program